ORAMED PHARMACEUTICALS INC (ORMP) Institutional Ownership Changes & 13F Activity

ORAMED PHARMACEUTICALS INC (ORMP) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy200147,700$502,180
Q4 2025Renaissance Technologies LLCSell-1,400147,500$420,375
Q3 2025Renaissance Technologies LLCBuy4,700148,900$393,096
Q2 2025Renaissance Technologies LLCBuy1,700144,200$324,450
Q1 2025Renaissance Technologies LLCSell-9,308142,500$304,950
Q4 2024Renaissance Technologies LLCSell-93,492151,808$367,375
Q3 2024Renaissance Technologies LLCBuy14,500245,300$598,532
Q2 2024Renaissance Technologies LLCBuy108,700230,800$593,156
Q1 2024Renaissance Technologies LLCSell-218,973122,100$357
Q4 2023Renaissance Technologies LLCBuy296,773341,073$788
Q3 2023Renaissance Technologies LLCBuy10,60044,300$116
Q2 2023Renaissance Technologies LLCBuy21,80033,700$121
Q1 2023Renaissance Technologies LLCSell-347,79711,900$26
Q2 2022Renaissance Technologies LLCBuy156,497359,697$1,647
Q4 2021Renaissance Technologies LLCSell-169,215203,200$2,902
Q4 2020Renaissance Technologies LLCSell-96,200372,415$1,579
Q3 2020Renaissance Technologies LLCBuy244,300468,615$1,223
Q2 2020Renaissance Technologies LLCBuy35,900224,315$792
Q1 2020Renaissance Technologies LLCSell-39,310188,415$573
Q4 2019Renaissance Technologies LLCBuy15,800227,725$1,173
Q3 2019Renaissance Technologies LLCBuy53,827211,925$676
Q2 2019Renaissance Technologies LLCBuy53,043158,098$568
Q1 2019Renaissance Technologies LLCBuy46,527105,055$382
Q4 2018Renaissance Technologies LLCBuy17,68358,528$176
Q3 2018Renaissance Technologies LLCSell-28,95540,845$199
Q1 2018Renaissance Technologies LLCSell-23,70069,800$454
Q4 2017Renaissance Technologies LLCBuy10,50093,500$842
Q3 2017Renaissance Technologies LLCBuy57,90083,000$824
Q2 2017Renaissance Technologies LLCBuy25,10025,100$195

Frequently asked questions about ORMP activity

  • Which institutional owners are buying ORMP?

    Institutional owners buying ORMP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ORMP activity?

    "Buy" means an investor increased their reported position in ORMP compared to the prior reporting period. This reflects growing exposure to ORAMED PHARMACEUTICALS INC (ORMP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ORMP increasing?

    Institutional interest in ORMP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ORMP insights